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significantly by baseline function, pain, and co-morbid conditions
prior to surgery and variability of outcome was most pronounced
by hip-associated pain before surgery. In addition, self-reported
back pain prevalent in 36% of individuals undergoing THR pre-
dicted early outcome independent of other co-morbid conditions
and hip-associated pain or function.
A47
THE RELATIONSHIP BETWEEN STATIC LOWER LIMB
ALIGNMENT AND DYNAMIC KNEE VARUS MOMENT IN
PATIENTS OF KNEE OSTEOARTHRITIS DEPENDS ON
DISEASE GRADE
K. Naito1, W. Kakihana1, R. Kuramochi2, S. Torii2, K. Akita3,
K. Nakazawa1, M. Akai1, T. Fukubayashi2
1National Rehabilitation Center for Persons with Disabilities,
Tokorozawa, Japan, 2Waseda University, Facurity of Sports
Sciences, Tokorozawa, Japan, 3Waseda University, Graduate
School of Sports Sciences, Tokorozawa, Japan
Purpose: Dynamic knee varus moment is an important factor
concerning disease progression in knee osteoarthritis (OA). We
have reported that the correlation coefficient between static lower
limb alignment and dynamic knee varus moment was higher
in asymptomatic subjects than in knee OA patients (OARSI
2004). However, it is still unknown if the relationship between
static alignment and dynamic varus moment is constant between
disease states. The aim of this study, therefore, was to compare
the relationship between static lower limb alignment and dynamic
knee external varus moment during level walking in patients with
different stages of knee OA.
Methods: The study design was a cross-sectional group com-
parison of different disease stages. Sixty-three elderly woman
aged from 50 to 70 years with symptomatic medial knee OA
participated in this study. Subjects were classified into 4 disease
grades according to the Kellgren & Lawrence scale. Because
the number of subjects in grades 3 and 4 were small, however,
the data from these groups were combined, resulting in 3 test
groups: Grade 1 (n=35), Grade 2 (n=28), and Grade 3-4 (n=6).
Static alignment of both legs during standing was captured by
leg-length X-ray pictures and then assessed by the Femorotibial
angle (FTA). Dynamic varus moment of the affected knee during
the stance phase of level walking along a 10 m path was deter-
mined through inverse dynamics. Kinematic data were recorded
with a VICON 512 motion analysis system (Oxford Matrix), and
ground reaction forces were measured with an imbedded force
platform (Kistler). The knee varus moment was calculated with an
in-house program written in Mathematica (Wolfram Research).
The walking speed was self-selected by the subjects. Pearson
correlation coefficients were used to determine significant corre-
lations between FTA and dynamic knee varus moment.
Results: There were significant positive correlations (p < 0.05)
between FTA and dynamic knee varus moment during gait in all
groups (Grade 1: r = 0.45, Grade 2: r = 0.46, Grade 3-4: r = 0.42).
However, compared to asymptomatic subjects, correlations were
weaker (OARSI 2004), and the slopes of the regression lines
decreased with disease progression (Grade 1: y=0.0135x-2.06,
Grade 2: y=0.0123x-1.85, Grade 3-4: y=0.0034x-0.25). The flat
slope of regression line in Grade 3-4 subjects shows that high
varus moment was independent of static alignment. However,
Grade 3-4 subjects did have higher static alignment and knee
varus moment values than the other groups.
Conclusions: The relationship between static lower limb align-
ment and dynamic knee varus moment was shown to vary
dependent on the disease stage of the subject. The linear re-
lationship between static alignment and dynamic moment seen
in asymptomatic subjects differed in OA subjects due to individ-
ual variability in dynamic knee varus moment. The more severe
subjects had high dynamic varus moment values that were in-
dependent of static alignment. The dynamic knee varus moment
induced by specific gait characteristics in OA patients is likely
the most important factor related to disease progression. Further
study with a greater number of patients is required to confirm the
trends found in this study.
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Purpose: Medial knee osteoarthritis (OA) is associated with
abnormally high medial compartment knee joint loading, as as-
sessed by the external knee adduction moment (AddM) during
gait; concomitantly, the external hip AddM has been observed
to be reduced in patients with moderate to severe knee OA
(Kellgren-Lawrence (K/L) grade ≥ 3). Further, a reduced external
hip AddM has recently been associated with an increased risk
of progression of OA at the knee. The purpose of this study was
(a) to characterize the biomechanical alterations at the hip that
are associated with mild medial compartment knee OA and (b)
to study the feasibility of focused muscle training designed to
strengthen hip abductors and subsequently to affect loading at
the knee joint.
Methods: 61 patients (45F/16M, age 55±9 years (mean±SD),
and BMI 28±4 kg/m2) with predominant medial knee OA were
recruited based on radiographic (K/L grade 2 index knee; 1-2
contralaterally) and pain (ambulatory pain>30mm of 100mm-
VAS) criteria. Subjects were otherwise healthy and without ex-
cess malalignment of mechanical axis, intrinsic foot disease, or
other lower extremity OA. 57 radiographically normal subjects
(43F/14M), with similar age and BMI, who were asymptomatic
(pain<10mm VAS) in both lower extremities served as a com-
parator group. Three-dimensional kinematics and kinetics were
obtained from the knee and the hip at a self-selected walking
speed in the gait laboratory for all subjects. External moments
(reported in %body weight * height) at the knee and the hip of
both groups were compared using independent samples T-tests.
Four subjects with symptomatic radiographic knee OA (3F/1M)
underwent a regimen of focused hip muscle training targeting
gluteus medius, tensor fascia latae and gluteus maximus. The
strengthening program, which also included hamstrings, quadri-
ceps, and the short hip adductors to maintain muscle balance,
lasted for 4 weeks. Each participant was evaluated prior to initi-
ation of physical therapy and after completion of the program.
Results: The self-selected gait speed of the OA population was
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generally slower than that of the comparator group, i.e. 1.21±
0.21 vs. 1.31± 0.23 m/s (p= 0.017). Despite diminished walking
speed, the external knee AddM was significantly higher in the
OA group than in the comparator group (2.9±0.7 vs. 2.2±0.7;
p<.001), while the hip AddM was reduced (3.9±0.8 vs. 4.3 ±0.9,
p=0.02). After completion of the strengthening program, the
self-selected normal speed of the four pilot patients increased
by 5.6% compared to the initial base values. In addition, the
external the knee AddM decreased by 3.6%, while the hip AddM
increased by 9.6%.
Conclusions: In accordance with previous observations, these
data suggest that in mild knee OA, the increased loading at
the knee is accompanied by decreased loading at the hip. The
chronically reduced recruitment of hip abductors stabilizing the
external hip AddM may result in hip muscle weakness over time,
and thus cause an unstable pelvis during gait yielding higher
medial loads at the knee. In our pilot patients, a focused hip
muscle strengthening program favorably altered both hip and
knee joint moments in subjects with knee OA, likely through
postural adaptations at the trunk and pelvis during gait. This
initial work suggests that focused muscle strengthening may
be a promising intervention for reducing medial compartment
loading patterns in subjects with knee OA.
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Purpose: Loss of meniscus tissue frequently leads to decreased
clinical function and activity levels. However, no report has quan-
tified the amount of meniscus tissue removed at meniscectomy
and correlated the meniscus tissue loss with clinical symptoms,
function, and activity. The purpose of this study was to determine,
prospectively, the amount of tissue loss at time of partial medial
meniscectomy and then correlate extent of meniscus loss with
clinical symptoms, function, and activity levels 2 years following
the index meniscectomy.
Methods: In a randomized controlled investigational device clin-
ical trial (Level of Evidence I), 149 patients 18 to 60 years old
underwent partial medial meniscectomy and served as controls.
There were 81 acute (no prior meniscus surgery) and 68 chronic
(1 to 3 prior partial meniscectomies on the involved meniscus)
patients. At index surgery, size of the meniscus defect was
measured using specially designed instruments, and percent of
meniscus loss was calculated based on actual measurements.
Patients were followed clinically for a minimum of 2 years follow-
ing meniscectomy. At each follow-up, every patient completed
questionnaires including Lysholm and Tegner scores to assess
function and activity. Amount of meniscus tissue at index surgery
was correlated with the individual domains of the Lysholm scale.
Tegner index was calculated to determine the amount of lost
activity regained 2 years after surgical intervention.
Results: Two-year data were available for 127 patients
(85% follow-up). There was a significant correlation between
the amount of meniscus tissue remaining following the in-
dex meniscectomy and 2-year Lysholm domains of squat-
ting (r=0.281, p=0.001), stair-climbing (r=0.251, p=0.004), and
swelling (r=0.261, p=0.003). In particular, it is noteworthy that
patients who had >50% of their meniscus remaining had sig-
nificantly better function than patients who had <50% menis-
cus remaining. Patients who had worse or no improvement in
pain symptoms at 2 years averaged 42% meniscus remaining,
while patients who had improved pain scores had on average
51% meniscus remaining. Tegner index for patients with <50%
meniscus remaining averaged 24%, and for patients with >50%
meniscus remaining averaged 52% (p=0.017); hence, a greater
amount of meniscus tissue remaining allowed patients to regain
significantly more of their lost activity.
Conclusions: There is a significant correlation between the
amount of meniscus tissue removed at meniscectomy and symp-
toms, function, and activity 2 years after surgery. This study con-
firms the importance of preserving as much meniscus tissue as
possible at the time of meniscus repair or meniscectomy as well
as the potential positive benefits of regrowing or replacing lost
meniscus tissue in order to minimize clinical symptoms that may
be suggestive of early degenerative changes.
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Purpose: RN624 is a humanized IgG2 monoclonal antibody
against human nerve growth factor (NGF). NGF is elevated in
conditions of acute and chronic pain and facilitates the impulse
flow in sensory neurons. RN624 has been effective in animal
pain models including arthritis pain, cancer pain and incision
pain. The objective of the first in human clinical study, Protocol
RN624-CL001, was to evaluate the safety and activity of a single
intravenous dose of RN624 in subjects with pain due to knee
OA.
Methods: 121 subjects with knee OA and a knee pain of ≥25
(VAS 0-100) were enrolled in a phase 1 double blinded, random-
ized, placebo controlled trial. The study was conducted in two
parts; a dose escalation (Part 1) followed by a parallel arm (Part
2). 42 subjects (12 placebo, 30 active) were enrolled in 5 dose
escalation cohorts to receive 3, 10, 30, 100, 300, and 1000 μg/kg
RN624 or placebo with 28 days inter-cohort intervals. Once the
safety of RN624 was established in Part 1, 79 subjects were en-
rolled in Part 2 and received either 100 or 300 μg/kg RN624 or
placebo in parallel (N = 27, 26 and 26 respectively). All subjects
received a single infusion of RN624 and were followed for up
to 180 days. Subjects recorded pain scores (VAS 0-100) for the
index knee 4 times a day and walking pain once a day or 28
days in the 3, 10, 30 μg/kg doses and up to 180 days in higher
dose groups. The WOMAC scale was administered during office
visits.
Results: Significant reduction in overall knee pain and walking
pain was observed in doses of 10 μg/kg RN624 and higher
of RN624. The peak effect was achieved by week 4 and was
sustained up to 12 weeks in 100 μg/kg and higher. More than
50% of subjects in 100 μg/kg or higher groups (N=71) experi-
enced at least a 50% reduction in walking pain over 12 weeks
compared to 25% in their placebo counterparts (N=32). A subset
of subjects in 100 μg/kg or higher displayed a transient reduced
efficacy in the 2nd and 3rd weeks; they experienced pain reduc-
tion during the 1st week, decreased pain reduction during the 2nd
and 3rd weeks, and sustained pain reduction up to 12 weeks.
Approximately 55% of subjects who received a single infusion of
100 μg/kg RN624 or higher achieved at least 50% improvement
in WOMAC function and stiffness subscales over 12 weeks post
infusion.
Approximately 25% of RN624 subjects reported adverse events
of altered or abnormal sensation of pain such as dysesthesia,
parasthesia, hyperesthesia, and allodynia. None of these events
were reported in the 3, 10, or 30 μg/kg RN624 groups (N=12).
These events were generally mild to moderate in severity and
transient. They mostly emerged during the first 2 weeks and
